First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: The SUSKA study, a non-randomized comparison from the VACH cohort

Pere Domingo, Ignacio Suárez-Lozano, Ferran Torres, Ramón Teira, José Lopez-Aldeguer, Francesc Vidal, Agustín Muñoz, Pompeyo Viciana, Fernando Lozano, Antonio Vergara, Bernadino Roca, Ma Luisa García Alcalde, Jaime Cosín, Alberto Terrón, Ma José Galindo, Paloma Geijo, Esteban Ribera, Juan Gonzalez, Trinitario Sanchez, Juan Ramón LacalleMyriam Garrido

Research output: Contribution to journalArticleResearchpeer-review

28 Citations (Scopus)

Fingerprint Dive into the research topics of 'First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: The SUSKA study, a non-randomized comparison from the VACH cohort'. Together they form a unique fingerprint.

Medicine & Life Sciences